Gene mutation allows aspirin’s anti-polyp effect
|
Tweet
|
|
Regular aspirin use reduces the risk of colon polyps in women with a common gene mutation that slows aspirin breakdown, a new study shows. In contrast, when this mutation is absent, aspirin seems to have no effect on polyp risk.
From 50 to 60 percent of the Caucasian population carries at least one copy of the variant gene, Andrew T. Chan of Massachusetts General Hospital in Boston told AMN Health.
Previous research has linked the mutation to a stronger effect of aspirin on polyp risk, he notes. “Our study extends these findings by demonstrating this in a” forward-looking study, which minimizes the chances that patients incorrectly remember their aspirin use, Chan said.
The investigation, which included 1,062 women participating in the Nurse’s Health Study, also was able to evaluate the effects of aspirin use at different doses. The findings are published in the Journal of the National Cancer Institute.
In the 616 women with the gene mutation, the researchers found that those who took two or more standard aspirin tablets each week reduced their risk of polyps by 34 percent. The reduction increased with the dose, with women taking more than seven tablets weekly cutting their risk 59 percent.
But in women without the gene variant, aspirin did not cut the risk of polyps, and higher doses produced no increased benefit.
“I don’t think we’re prepared to say that it doesn’t benefit people with the normal gene at all, but it does seem to be a smaller benefit,” Chan said.
Before these findings can be applied clinically, he added, further studies are needed to determine if people with the gene variant are also more likely to experience side effects from aspirin, such as stomach bleeding.
Chan said his team also hopes to look at how the gene variation affects other outcomes related to aspirin use, such as the drug’s cardioprotective effects.
In the meantime, he added, the only proven Colon cancer prevention method remains regular screening. “It’s still very important that people pursue recommended screening for prevention.”
SOURCE: Journal of the National Cancer Institute, March 15, 2005.
Revision date: July 7, 2011
Last revised: by Janet A. Staessen, MD, PhD
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Best time for a coffee break? There’s an app for that
- Full Story - - »»»
Cellphone Use Linked to Selfish Behavior in UMD Study
- Full Story - - »»»
Optimism about heart risks may be a good thing
- Full Story - - »»»
New guidelines developed for improved DVT diagnosis
- Full Story - - »»»
Teen pregnancy, abortion rates at record low, study says
- Full Story - - »»»
Think you can’t get pregnant? Try again, study says
- Full Story - - »»»

